Viridian Therapeutics Inc (NASDAQ: VRDN): Stock Investors Should Also Pay Attention To This Stock
During the last session, Viridian Therapeutics Inc (NASDAQ:VRDN)’s traded shares were 1.01 million, with the beta value of the company hitting 1.11. At the end